Jenkins Patrick, Cross Cory, Abdo Tony, Youness Houssein, Keddissi Jean
Section of Pulmonary, Critical Care and Sleep Medicine, The Oklahoma City VA Healthcare System and The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Diagnostics (Basel). 2024 Jul 19;14(14):1565. doi: 10.3390/diagnostics14141565.
Systemic steroids are frequently used in critically ill patients for their anti-inflammatory properties. Potential benefits of these agents should be balanced against their known side effects. In this paper, we review trials assessing the use of systemic steroids in common conditions requiring admission to the intensive care unit. These include septic shock, the acute respiratory distress syndrome, severe pneumonia, COVID-19, and hypercapnic respiratory failure due to chronic obstructive pulmonary disease. We will mainly focus on well-conducted randomized controlled trials to determine whether steroids should be administered to critically ill patients presenting with these conditions.
全身用类固醇因其抗炎特性而经常用于重症患者。这些药物的潜在益处应与其已知的副作用相权衡。在本文中,我们回顾了评估全身用类固醇在需要入住重症监护病房的常见病症中的应用的试验。这些病症包括感染性休克、急性呼吸窘迫综合征、重症肺炎、COVID-19以及慢性阻塞性肺疾病所致的高碳酸血症性呼吸衰竭。我们将主要关注精心设计的随机对照试验,以确定是否应将类固醇用于患有这些病症的重症患者。